MedUni Wien Researcher of the Month März 2013

Grimm C, Polterauer S, Natter C, Rahhal J, Hefler L, Tempfer CB, Heinze G, Stary G, Reinthaller A, Speiser P. Treatment of cervical intraepithelial neoplasia with topical imiquimod—a randomized controlled trial. Obstet Gynecol. 2012;120(1):152–9. Grimm C, Watrowski R, Baumühlner K, Natter C, Tong D, Wolf A, Zeillinger R, Leodolter S, Reinthaller A, Hefler L. Genetic variations of interleukin-1 and -6 genes and risk of cervical intraepithelial neoplasia. Gynecol Oncol. 2011;121(3):537–41. Grimm C, Watrowski R, Polterauer S, Baumühlner K, Natter C, Rahhal J, Heinze G, Schuster E, Hefler L, Reinthaller A. Vascular endothelial growth factor gene polymorphisms and risk of cervial intraepithelial neoplasia. Int J Gyn Cancer. 2011;21(4):597–601. Hefler L, Grimm C, Tempfer C, Reinthaller A. Treatment with vaginal progesterone in women with low-grade cervical dysplasia: a phase II trial. Anticancer Res. 2010;30(4):1257–61. Hefler LA, Grimm C, Speiser P, Sliutz G, Reinthaller A. The cyclooxygenase-2 inhibitor rofecoxib (Vioxx(®)) in the treatment of cervical dysplasia grade II-III a phase II trial. Eur J Obstet Gynecol Reprod Biol. 2006;125(2):251–4. Hefler L, Grimm C, Kueronya V, Tempfer C, Reinthaller A, Polterauer S. A novel training model for the loop electrosurgical excision procedure: an innovative replica helped workshop participants improve their LEEP. Am J Obstet Gynecol. 2012;206(6):535.e1–4. Polterauer S, Grimm C, Hofstetter G, Concin N, Natter C, Sturdza A, Pötter R, Marth C, Reinthaller A, Heinze G. Nomogram prediction for overall survival of patients diagnosed with cervical cancer. Br J Cancer. 2012. doi: 10.1038/bjc.2012.340. Polterauer S, Hefler L, Seebacher V, Rahhal J, Tempfer C, Horvat R, Reinthaller A, Grimm C. The impact of lymph node density on survival of cervical cancer patients. Br J Cancer. 2010;103(5):613–6.